Detailed price information for Abbott Laboratories (ABT-N) from The Globe and Mail including charting and trades.

One day after discovering unauthorized access to its Quanum LSM system, Quest filed an SEC disclosure acknowledging that ...

Quest said it paused access to the system as soon as it discovered the incident and is working towards 'full restoration' as ...

Abbott Laboratories came into this Q3 2026 report with a rich valuation and a reputation as a dependable healthcare compounder, yet the stock had slipped over the last month. Today, the shares are ...

As harvest continues across Ohio, farm budgets and fertilizer expenses are facing intense scrutiny ahead of the 2027 growing ...

Oct 22 (Reuters) - Quest Diagnostics on Thursday said it learned of unauthorized access to its Quanum LSM system, which some ...

Quest Diagnostics is the latest medtech company to disclose that it was hit by a cyberattack.

If $45.88 breaks decisively, BSX20261030C38.5 offers direct bullish exposure with minimal delta risk.

According to MarketsandMarkets™, the Immunoassay Market is projected to reach USD 44.49 billion by 2031 from USD 31.65 ...

Abbott plans to spin off its $8.5B Nutrition business by 2027 while cutting its 2026 sales growth outlook amid diabetes pricing and electrophysiology challenges.

Officials confirmed the first detection of New World screwworm in U.S. wildlife after the flesh-eating parasite was ...

At the 2026 Chery International User Summit, CHERY highlighted vehicle safety, while the AiMOGA Robotics Global Launch ...